Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
216
-
Total 13F shares, excl. options
-
61M
-
Shares change
-
-2.4M
-
Total reported value, excl. options
-
$4.02B
-
Value change
-
-$119M
-
Put/Call ratio
-
0.57
-
Number of buys
-
101
-
Number of sells
-
-106
-
Price
-
$65.89
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2022
263 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q3 2022.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 216 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61M shares
of 62.5M outstanding shares and own 97.54% of the company stock.
Largest 10 shareholders include FMR LLC (8.96M shares), BlackRock Inc. (5.76M shares), VANGUARD GROUP INC (5.66M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.03M shares), WELLINGTON MANAGEMENT GROUP LLP (3.82M shares), T. Rowe Price Investment Management, Inc. (2.26M shares), STATE STREET CORP (2.22M shares), Casdin Capital, LLC (1.7M shares), MORGAN STANLEY (1.54M shares), and Rock Springs Capital Management LP (1.54M shares).
This table shows the top 216 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.